Skip to main content

Table 2 Treatment-related toxicities of all 19 patients enrolled.

From: Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma

  Number of patients (%)
NCI-CTC Grade 1 2 3 4
Leukopenia 2 (11) 6 (32) 3 (16) 0
Neutropenia 3 (16) 1 (5) 2 (11) 2 (11)
Anemia 0 1 (5) 0 0
Thrombocytopenia 3 (16) 3 (16) 0 1 (5)
Diarrhea 1 (5) 1 (5) 0 0
Nausea/emesis 5 (26) 2 (11) 0 0
Stomatitis 3 (16) 2 (11) 1 (5) 0
  1. NCI-CTC: National Cancer Institute Common Toxicity Criteria